Kimberlynn B. Davis focuses her practice on prosecuting foreign and domestic patent applications in the chemical arts, due diligence and freedom to operate analysis, and client counseling and portfolio strategy for companies, universities and research institutions. Prior to joining the firm, Dr. Davis was a patent agent with an Atlanta IP law firm. While attending graduate school, she designed and synthesized nucleoside analogues as HIV-1 reverse transcriptase inhibitors and also focused on developing methodology to improve the regioselectivity of nucleoside base couplings under advisor Dr. Dennis Liotta. Dr. Davis also served as an intern in the Emory University Office of Technology Transfer, where she assessed the marketability and patentability of technologies. While attending Xavier University of Louisiana, Dr. Davis worked as a summer intern in medicinal chemistry at Eli Lilly and Company.
Dr. Davis has co-authored scientific and legal journal manuscripts and presented at several scientific meetings. She is a recipient of Apex Society’s Power 30 Under 30™ Award, was recognized as a Superwoman of the Future by Atlanta Tribune Magazine, and has been profiled by Rolling Out Atlanta Magazine.
During law school, Dr. Davis received the GSU College of Law Intellectual Property Scholarship and served as a graduate research assistant for the GSU Intellectual Property Advisory Board.
Dr. Davis was recognized in 2018 as a Georgia “Rising Star” in the area of Intellectual Property by Super Lawyers magazine.
- Georgia State University, College of Law, J.D. (2013) magna cum laude
- Emory University, Ph.D., Organic Chemistry (2008)
- Xavier University of Louisiana, B.S., Biochemistry (2004) summa cum laude
- Georgia (2014)
- U.S. Patent and Trademark Office (2009)
Rate : $$$$